
GELS
Healthcare · Drug Manufacturers - Specialty & Generic · $4.1M market cap
$0.3803-0.00 (-0.1%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 3 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 17, 2025 | Time not confirmed | — | -0.34 | — |
| Jun 30, 2025 | Time not confirmed | — | -0.38 | — |
| Nov 15, 2024 | Time not confirmed | — | -0.14 | — |
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.